Lexeo Therapeutics, Inc. (LXEO) - Total pendapatan perusahaan
The high risk of a biotech model with fixed platform costs creates volatility, which is evident in the commercial implementation volumes of Lexeo Therapeutics (LXEO), where the current status is 0.00. Growth potential is based on insurance fund reimbursement for therapy courses in the treatment of Alzheimer's. The strategy relies on accelerating clinical trials and protecting unique DNA vectors to overcome stagnation.
Rincian metrik komprehensif lan analitis Lexeo Therapeutics Inc. (LXEO)
- rega saham lan prakiraan rega para ahli:
- indikator kapitalisasi pasar:
- indikator nilai buku ekuitas:
- data liabilitas lan likuiditas perusahaan:
Utang Agregat marang Ekuitas Lexeo Therapeutics|LXEO - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Lexeo Therapeutics, Inc.|LXEO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Lexeo Therapeutics, Inc.|LXEO - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Lexeo Therapeutics|Koefisien jangkoan perantara lexeotx.com
- indikator bathi lan kelipatan valuasi:
LXEO - Bathi resik|Bathi mangsa ngarep Lexeo Therapeutics|LXEO - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi lexeotx.com|LXEO - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Lexeo Therapeutics, Inc.|LXEO - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone 12 wulan pungkasan Lexeo Therapeutics|LXEO - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan lexeotx.com|LXEO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Lexeo Therapeutics
- statistik dodolan lan pendapatan perusahaan:
Analisis umum perusahaan:LXEO, Lexeo
Institutional capital evaluates Lexeo Therapeutics (LXEO) through the lens of cash flow sustainability. This indicator captures daily sales volume, eliminating the time lag associated with quarterly reporting. By analyzing the revenue dynamics from the company's product sales, investors can see the real-time market reaction to innovations in gene therapy. For this DNA medicine scientific hub, this confirms the commercial viability of its developments. A stable chart guarantees the reliability of the asset.
Perusahaan pesaing
Tempus AI, Inc. (TEM) - Pendapatan reged perusahaan|Dodolan perusahaan QGEN (Qiagen NV)|Pendapatan lan volume dodolan Ionis Pharmaceuticals, Inc. (IONS)|Pendapatan lan volume dodolan RGEN (Repligen Inc.)|Avidity Corp (RNA) - Total pendapatan perusahaan|CRSP - Pendapatan perusahaan|Pendapatan reged perusahaan genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Pendapatan perusahaan|Total pendapatan perusahaan Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Pendapatan lan volume dodolan|Total pendapatan perusahaan Twist Bioscience Corp TWST|Pendapatan lan volume dodolan TXG|Pendapatan lan volume dodolan intelliatx.com (NTLA)|Stoke Therapeutics - Dodolan perusahaan|BioLife Solutions Inc (BLFS) - Total pendapatan perusahaan|wavelifesciences.com - Pendapatan lan volume dodolan|Maze Therapeutics Corp (MAZE) - Dodolan perusahaan|SION: Pendapatan lan volume dodolan|Volume dodolan perusahaan PRME|Pendapatan perusahaan Taysha Gene Therapies|Volume dodolan perusahaan QURE (uniQure)|Pendapatan perusahaan MeiraGTx (MGTX)|REGENXBIO Corp - Volume dodolan perusahaan|Pendapatan perusahaan Solid Biosciences SLDB|OCGN - Dodolan perusahaan|pacb.com - Pendapatan lan volume dodolan|Benitec (BNTC) - Dodolan perusahaan|DSGN: Pendapatan lan volume dodolan|RCKT - Pendapatan reged perusahaan|FDMT: Pendapatan reged perusahaan|Total pendapatan perusahaan korrobio.com KRRO|Dodolan perusahaan EDIT (Editas Medicine, Inc.)|Silence Therapeutics plc - Volume dodolan perusahaan|Pendapatan perusahaan ProQR Therapeutics N.V. PRQR|Pendapatan reged perusahaan Codexis, Inc. (CDXS)|SGMO - Pendapatan perusahaan|nautilus.bio - Total dodolan perusahaan|Metagenomi, Inc (MGX) - Pendapatan perusahaan|Volume dodolan perusahaan DTIL|Pendapatan perusahaan Generation Bio|Pendapatan lan volume dodolan Boundless Bio Inc|Pendapatan perusahaan Exicure Corp (XCUR)|Pendapatan reged perusahaan Imunon|Pendapatan lan volume dodolan PHIO (phiopharma.com)|Total volume dodolan perusahaan mustangbio.com|RNAZ - Pendapatan perusahaan|Total pendapatan perusahaan Bionano Genomics|APDN: Pendapatan lan volume dodolan|Volume dodolan perusahaan BLUE|Dodolan perusahaan IPA|OMGA: Pendapatan dodolan perusahaan|Pendapatan lan volume dodolan OMIC|Pendapatan reged perusahaan Regulus Therapeutics|Pendapatan perusahaan Syros SYRS|Pendapatan dodolan perusahaan TBIO|TCON: Dodolan perusahaan|Unity Biotechnology, Inc. (UBX) - Dodolan perusahaan
